LabCorp received authorization for COVID-19 sample pooling
On Jul. 25, 2020, LabCorp announced it received an Emergency Use Authorization from the FDA permitting diagnostic testing…
-
-
CDC released new resources and tools to support opening schools
On Jul. 23, 2020, the Centers for Disease Control and Prevention (CDC) released new science-based resources and tools…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Dynavax and Medigen announced collaboration to develop a novel adjuvanted COVID-19 vaccine candidate
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics announced their collaboration to develop an adjuvanted vaccine…
-
Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
-
AXIM Biotechnologies released Rapid NeuCovix test results showing strong agreement with COVID-19-based neutralization tests
On Jul. 23, 2020, AXIM Biotechnologies announced the completion of a study highlighting the performance of NeuCovix™, AXIM’s…
-
NIH leadership detailed unprecedented initiative to ramp up testing technologies for COVID-19
On Jul. 22, 2020, In a paper in the New England Journal of Medicine, scientific leaders from the…
-
RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
-
COVID-19 antibodies decay quickly after mild illness
On Jul. 22, 2020, University of California at Los Angeles researchers reported that they found. levels of antibodies…
-
COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
On Jul. 22, 2020, the World Health Organization (WHO) and UNICEF announced the COVID-19 Law Lab initiative which…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Vaccine
University of British Columbia scientists sequence genomes of Canadians with COVID-19
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
-
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVID single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmune’s single-dose intranasal vaccine…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
-
Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
-
BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
-
PerkinElmer released new dried blood spot based COVID-19 serology test
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
-
Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples
On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…
-
COVID-19 vaccine trials conducted at Washington University, Saint Louis University
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
-
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
-
FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19
On Jul. 20, 2020, Sorrento received clearance from the U.S. Food and Drug Administration (FDA) to initiate a…
-
Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program
On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…
-
Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line
On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…
-
OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract
On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced it will accept an Indefinite Delivery Indefinite…
-
Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
-
Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study
On Jul. 20, 2020, Pfizer and BioNTech announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
-
Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
On Jul. 20, 2020, Luminex announced the Food and Drug Administration (FDA) had issued an Emergency Use Authorization…
-
The FDA FDA Issued first Emergency Authorization for sample pooling in diagnostic testing
On Jul. 18, 2020, the U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to…
-
COVID-19 antibody tests evaluated as diagnostic test in low-resource settings
On Jul. 18, 2020, with Brazil leading the world in newly diagnosed COVID-19 cases, Latin America has become…
-
Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTI for treatment of COVID-19
On Jul. 16, 2020, Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study…
-
Telesis Bio Releases New Synthetic SARS-CoV-2 Genome for COVID-19 Vaccine and Therapeutic Research
On Jul. 16, 2020, Telesis Bio announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
-
Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
